NIRSEVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

IMMUNOGLOBULIN G1, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN)(HUMAN MONOCLONAL MED18897 .GAMMA.1-CHAIN), DISULFIDE WITH MONOCLONAL MED18897 .KAPPA.-CHAIN, DIMER

Preferred Name

English

NIRSEVIMAB

Official Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN F0 (PROTEIN F))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-456) (HUMAN VH (HOMO SAPIENS IGHV1-69*01(IGHD)-IGHJ4*01 (90.1%)) (8.8.19) (1-126) -HOMO SAPIENS IGHG1*03

Systematic Name

English

Nirsevimab [WHO-DD]

Common Name

English

NIRSEVIMAB [USAN]

Common Name

English

NIRSEVIMAB [JAN]

Common Name

English

MED-18897

Code

English

nirsevimab [INN]

Common Name

English

MEDI8897

Code

English

Code System Code Type Description

DAILYMED

VRN8S9CW5V

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

USAN

FG-140

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

FDA UNII

VRN8S9CW5V

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

CAS

1989556-22-0

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

NO STRUCTURE GIVEN

SMS_ID

100000177600

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

INN

10780

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

NCI_THESAURUS

C170224

Created by admin on Tue Apr 01 20:59:28 GMT 2025 , Edited by admin on Tue Apr 01 20:59:28 GMT 2025

PRIMARY

ACTIVE MOIETY


					VRN8S9CW5V